SEC Form 4 · accession 0000899243-18-018511
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt Graves
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jun 27, 2018 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.09 | Jun 26, 2018 | A | 15,000 | A | — | Jun 25, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in full on the earlier of June 26, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders.